A detailed history of Geode Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 9,937,604 shares of DXCM stock, worth $795 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,937,604
Previous 9,723,468 2.2%
Holding current value
$795 Million
Previous $1.1 Billion 39.59%
% of portfolio
0.05%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $13.7 Million - $24.9 Million
214,136 Added 2.2%
9,937,604 $666 Million
Q2 2024

Aug 09, 2024

BUY
$110.31 - $140.45 $60.1 Million - $76.6 Million
545,273 Added 5.94%
9,723,468 $1.1 Billion
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $29.8 Million - $36.6 Million
260,940 Added 2.93%
9,178,195 $1.27 Billion
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $14.2 Million - $23.4 Million
188,219 Added 2.16%
8,917,255 $1.11 Billion
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $14.8 Million - $23.6 Million
171,458 Added 2.0%
8,729,036 $814 Million
Q2 2023

Aug 11, 2023

BUY
$112.47 - $130.98 $30.9 Million - $36 Million
274,915 Added 3.32%
8,557,578 $1.1 Billion
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $17.8 Million - $21 Million
170,796 Added 2.11%
8,282,663 $962 Million
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $8.22 Million - $11.9 Million
96,683 Added 1.21%
8,111,867 $917 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $14.7 Million - $18.2 Million
192,962 Added 2.47%
8,015,184 $645 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $402 Million - $785 Million
5,910,597 Added 309.19%
7,822,222 $582 Million
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $4.07 Million - $5.64 Million
43,294 Added 2.32%
1,911,625 $976 Million
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $9.58 Million - $12 Million
73,778 Added 4.11%
1,868,331 $1 Billion
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $4.95 Million - $6.65 Million
46,427 Added 2.66%
1,794,553 $979 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $20.5 Million - $27.3 Million
252,773 Added 16.9%
1,748,126 $744 Million
Q1 2021

May 12, 2021

BUY
$84.79 - $104.74 $44,260 - $54,674
522 Added 0.03%
1,495,353 $536 Million
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $1.12 Million - $1.5 Million
-14,318 Reduced 0.95%
1,494,831 $551 Million
Q3 2020

Nov 13, 2020

BUY
$95.51 - $112.95 $4.53 Million - $5.35 Million
47,388 Added 3.24%
1,509,149 $621 Million
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $15 Million - $25.2 Million
239,457 Added 19.59%
1,461,761 $592 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $4.9 Million - $7.75 Million
102,430 Added 9.15%
1,222,304 $329 Million
Q4 2019

Feb 13, 2020

BUY
$36.62 - $57.29 $2.17 Million - $3.39 Million
59,161 Added 5.58%
1,119,874 $245 Million
Q3 2019

Nov 12, 2019

SELL
$35.53 - $43.8 $2.18 Million - $2.69 Million
-61,302 Reduced 5.46%
1,060,713 $158 Million
Q2 2019

Aug 14, 2019

BUY
$27.84 - $38.92 $428,680 - $599,290
15,398 Added 1.39%
1,122,015 $168 Million
Q1 2019

May 14, 2019

BUY
$28.07 - $38.18 $1.81 Million - $2.46 Million
64,486 Added 6.19%
1,106,617 $132 Million
Q4 2018

Feb 13, 2019

BUY
$26.99 - $37.37 $4.12 Million - $5.71 Million
152,781 Added 17.18%
1,042,131 $125 Million
Q3 2018

Nov 13, 2018

BUY
$23.35 - $36.72 $519,350 - $816,726
22,242 Added 2.57%
889,350 $127 Million
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $809,541 - $1.16 Million
46,154 Added 5.62%
867,108 $82.4 Million
Q1 2018

May 15, 2018

BUY
$13.06 - $18.54 $263,433 - $373,970
20,171 Added 2.52%
820,954 $60.9 Million
Q4 2017

Feb 13, 2018

BUY
$11.12 - $15.38 $93,897 - $129,868
8,444 Added 1.07%
800,783 $46 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $160,380 - $267,959
14,118 Added 1.81%
792,339 $38.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
778,221
778,221 $56.9 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.